<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03336723</url>
  </required_header>
  <id_info>
    <org_study_id>II10</org_study_id>
    <nct_id>NCT03336723</nct_id>
  </id_info>
  <brief_title>Two-Piece Zirconia Dental Implant vs Two-Piece Titanium Dental Implant- Randomized Clinical Control Trial</brief_title>
  <official_title>Inflammation and Microbiology Pattern on Two-piece Zirconia Dental Implant Compared to Titanium Dental Implants. Randomized Clinical Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Implantologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Implantologia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      2 Arms (60 subjects - 30 each arm). Experimental group with two-pice zirconia dental implant
      and Control group with two-piece titanium dental implant Evaluate Changes in inflammatory and
      microbiology levels from T0 (baseline) T2 (8 weeks) and T3 (after crown placement) Also
      evaluate secondary outcomes: marginal bone loss (MBL), gingival height (GH) levels,
      osseointegration, gender, age, time of surgery, anatomical position and implant stability. p
      values&lt;0.05 were considered statistically significant
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Osseointegration</measure>
    <time_frame>from T0 to T2 - 2 month</time_frame>
    <description>measure if the healing process of bone was successful</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Marginal bone loss</measure>
    <time_frame>4 month after T0</time_frame>
    <description>measure bone level from T0 baseline to T3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL1b concentration</measure>
    <time_frame>4 month</time_frame>
    <description>Measure IL fluid at T0 and T2 for IL1b characterization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL6 concentration</measure>
    <time_frame>4 month</time_frame>
    <description>Measure IL fluid at T0 and T2 for IL1b characterization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microbiologic samples</measure>
    <time_frame>4 month</time_frame>
    <description>Measure crevicular fluid at T0 and T2 for bacteria characterization</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Osseointegration Failure of Dental Implant Due to Infection</condition>
  <condition>Osseointegration Failure of Dental Implant Prior to Intentional Prosthetic Loading</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two piece zirconia dental implants place subcrestally with a healing abutment at baseline (T0) and rehabilitated with a zirconia dental crown T3 3 Measures on the IL1b and IL6 at T0 baseline , T2 2 month and T3 at crown placement.Microbiological samples at T2 and T3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two piece titanium dental implants place subcrestally with a healing abutment at baseline (T0) and rehabilitated with a zirconia dental crown T3 3 Measures on the IL1b and IL6 at T0 baseline , T2 2 month and T3 at crown placement.Microbiological samples at T2 and T3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental Implant</intervention_name>
    <description>Place a two piece zirconia dental implant on a healed ridge. At baseline, two month and crown placement take fluid samples with adsorbent paper in the per- implant crevicular fluid. At t2 and t3 repeat sample taken</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Single implants in any area (maxillary and mandibular), extracted teeth for at least 3
        months before implant placement, with bone volumes sufficient (at least 2 mm mesial,
        distal, buccal and palatal) to accommodate dental implant without the need for
        regeneration. Controlled oral hygiene, absence of any lesions in the oral cavity, at least
        2 mm keratinized tissue. In addition, patients must agree to participate in a postoperative
        control program and signed the informed consent.

        Exclusion Criteria:

        1 - allergic to local anaesthetics, or any of the other components. 2 - Patients with
        hepatic or renal dysfunction 3 - Patients with epilepsy, shock, cardiac conduction
        disorders or myasthenia gravis 4 - Patients with myocardial injury 5 - Hyperthyroidism 6 -
        Severe Hypertension 7 - Insufficient bone volume 8 - Smoking more than five cigarettes /
        day 9 - Excessive alcohol consumption 10 - localized anti-tumour radiation therapy of the
        oral cavity 11 - Chemotherapy 12 - Liver Diseases 13 - immunosuppressed patients 14 -
        Patients taking corticosteroids 15 - Pregnancy 16 - inflammatory and autoimmune diseases of
        the oral cavity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elena cervino, DMD</last_name>
    <phone>00351919774343</phone>
    <email>elecer@gmail.com</email>
  </overall_contact>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2017</study_first_submitted>
  <study_first_submitted_qc>November 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2017</study_first_posted>
  <last_update_submitted>November 5, 2017</last_update_submitted>
  <last_update_submitted_qc>November 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Implantologia</investigator_affiliation>
    <investigator_full_name>Andre Chen</investigator_full_name>
    <investigator_title>DMD</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

